Comparison of different miR-21 inhibitor chemistries in a cardiac disease model

J Clin Invest. 2011 Feb;121(2):461-2; author reply 462-3. doi: 10.1172/JCI45938. Epub 2011 Feb 1.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cardiomegaly / genetics*
  • Cardiomegaly / pathology
  • Cardiomegaly / therapy*
  • Clinical Trials as Topic
  • Disease Models, Animal*
  • Fibrosis
  • Genetic Therapy*
  • Humans
  • Mice
  • MicroRNAs / antagonists & inhibitors*
  • Myocardium / metabolism
  • Myocardium / pathology

Substances

  • MIRN21 microRNA, mouse
  • MicroRNAs